ALDX announced that the FDA has accepted its resubmitted new drug application (NDA) for reproxalap, a first-in-class ...

Whilst dry eyes can often be harmless, this symptom can also be a sign of far more serious health conditions so it is ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for reproxalap for the treatment of the signs and symptoms of dry eye disease. Reproxalap is a ...

Aldeyra (ALDX) announced FDA acceptance of its resubmitted market application for reproxalap and an expansion of its option agreement with AbbVie (ABBV). Read more here.

The FDA assigned a Prescription Drug User Fee Act (PDUFA) date of April 2, 2025, for reproxalap for patients with dry eye ...

As people, especially women, pass the age of 50, they become more at risk for Sjögren's syndrome. We asked a doctor about the ...

Discover how rising air pollution levels are linked to serious eye conditions, including dry eye disease and inflammation. Experts explain the impact of airborne pollutants on eye health and vision ...

ORLANDO, FL / ACCESSWIRE / November 15, 2024 / RedChip Companies will air interviews with MUSQ Global Music Industry ETF (NYSE:MUSQ) and OKYO Pharma Ltd. (Nasdaq:OKYO) on the RedChip Small Stocks, Big ...

Chinese researchers studied 299 participants ages 18 to 45 with dry eye disease, assigning half of them to a laughter ...

Do you suffer from dry eyes in the hotter months? From eyewear to diet and a warm compress, steps can be taken to improve ...